業績論文
（First author）

Araoka H, Baba M, Kimura M, Abe M, Inagawa H, Yoneyama A. Clinical characteristics of bacteremia caused by Helicobacter cinaedi and time required for blood cultures to become positive. J Clin Microbiol. 2014; 52(5): 1519-22.

Araoka H, Kimura M, Abe M, Takahashi N, Yoneyama A. Appropriate sampling sites for the surveillance of multidrug-resistant Pseudomonas aeruginosa colonization. Jpn J Infect Dis. 2014; 67(2): 118-9.

Araoka H, Fujii T, Izutsu K, et al. Rapidly progressive fatal hemorrhagic pneumonia caused by Stenotrophomonas maltophilia in hematologic malignancy. Transpl Infect Dis. 2012; 14(4): 355-63.

Araoka H, Baba M, Tateda K, et al; ABX Combination Therapy Study Group. In vitro combination effects of aztreonam and aminoglycoside against multidrug-resistant Pseudomonas aeruginosa in Japan. Jpn J Infect Dis. 2012; 65(1): 84-7.

Araoka H, Kimura M, Yoneyama A. A surveillance of high-level gentamicin-resistant enterococcal bacteremia. J Infect Chemother. 2011; 17(3): 433-4.

Araoka H, Baba M, Yoneyama A. Risk factors for mortality among patients with Stenotrophomonas maltophilia bacteremia in Tokyo, Japan, 1996-2009. Eur J Clin Microbiol Infect Dis. 2010; 29(5): 605-8.

Araoka H, Baba M, Takagi S, et al. Monobactam and aminoglycoside combination therapy against metallo-beta-lactamase-producing multidrug-resistant Pseudomonas aeruginosa screened using a 'break-point checkerboard plate'. Scand J Infect Dis. 2010; 42(3): 231-3.

（Co-author）
2015年

Imafuku A, Araoka H, Tanaka K, et al. Helicobacter cinaedi bacteremia in four renal transplant patients: clinical features and an important suggestion regarding the route of infection. Transpl Infect Dis. 2015 Sep 23 accepted.

Abe M, Araoka H, Kimura M, Yoneyama A. Varicella Zoster Virus Meningoencephalitis Presenting with Elsberg Syndrome without a Rash in an Immunocompetent Patient. Intern Med. 2015; 54(16): 2065-7.

Suwabe T, Araoka H, Ubara Y, et al. Cyst infection in autosomal dominant polycystic kidney disease: causative microorganisms and susceptibility to lipid-soluble antibiotics. Eur J Clin Microbiol Infect Dis. 2015; 34(7): 1369-79

Yamamoto H, Uchida N, Matsuno N, Araoka H, et al. I.v. BU/fludarabine plus melphalan or TBI in unrelated cord blood transplantation for high-risk hematological diseases. Bone Marrow Transplant. 2015; 50(4): 607-9.

2014年

Takagi S, Araoka H, Uchida N, et al. A prospective feasibility study of primary prophylaxis against invasive fungal disease with voriconazole following umbilical cord blood transplantation with fludarabine-based conditioning. Int J Hematol. 2014; 99(5): 652-8.

Abe M, Kimura M, Araoka H, Taniguchi S, Yoneyama A. Serum (1,3)-beta-D-glucan is an inefficient marker of breakthrough candidemia. Med Mycol. 2014; 52(8): 835-40.

Hosokawa K, Takami A, Tsuji M, Araoka H, et al. Relative incidences and outcomes of Clostridium difficile infection following transplantation of unrelated cord blood, unrelated bone marrow, and related peripheral blood in adult patients: a single institute study. Transpl Infect Dis. 2014; 16(3): 412-20.

2013年

Kimura M, Araoka H, Yoneyama A. Aeromonas caviae is the most frequent pathogen amongst cases of Aeromonas bacteremia in Japan. Scand J Infect Dis. 2013; 45(4): 304-9.

Kataoka H, Ida T, Ishii Y, Araoka H, et al, ABX Combination Therapy Study Group (ACTs). Analysis of the influence of drug resistance factors on the efficacy of combinations of antibiotics for multidrug-resistant Pseudomonas aeruginosa isolated from hospitals located in the suburbs of Kanto area, Japan. J Glob Antimicrob Resist. 2013 ;1:91-96.

2012年

Kimura M, Araoka H, Uchida N, et al. Cunninghamella bertholletiae pneumonia showing a reversed halo sign on chest computed tomography scan following cord blood transplantation. Med Mycol. 2012; 50(4): 412-6.

2011年

Nishida A, Miyamoto A, Yamamaoto H, Araoka H, et al. Possible association of trisomy 8 with secondary pulmonary alveolar proteinosis in myelodysplastic syndrome. Am J Respir Crit Care Med. 2011; 184(2): 279-80.

Uchida N, Wake A, Nakano N, Araoka H, et al. Mycophenolate and tacrolimus for graft-versus-host disease prophylaxis for elderly after cord blood transplantation: a matched pair comparison with tacrolimus alone. Transplantation. 2011; 92(3): 366-71.

Yamamoto H, Kato D, Uchida N, Araoka H, et al. Successful sustained engraftment after reduced-intensity umbilical cord blood transplantation for adult patients with severe aplastic anemia. Blood. 2011; 117(11): 3240-2.

2010年

Tasaka S, Tokuda H, Sakai F, Araoka H, et al. Comparison of clinical and radiological features of pneumocystis pneumonia between malignancy cases and acquired immunodeficiency syndrome cases: a multicenter study. Intern Med. 2010; 49(4): 273-81.

2009年

Matsuno N, Wake A, Uchida N, Araoka H, et al. Impact of HLA disparity in the graft-versus-host direction on engraftment in adult patients receiving reduced-intensity cord blood transplantation. Blood. 2009; 114(8): 1689-95.

Yamamoto H, Uchida N, Ishiwata K, Araoka H, et al. Possible graft-versus-host disease involving the central nervous system soon after cord blood transplantation. Am J Hematol. 2009; 84(11): 764-6.

Takagi S, Masuoka K, Uchida N, Araoka H, et al. High incidence of haemophagocytic syndrome following umbilical cord blood transplantation for adults. Br J Haematol. 2009; 147(4): 543-53.